These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1343662)

  • 1. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
    Machado ES; Braga Mda P; Da Cruz AM; Coutinho SG; Vieira AR; Rutowitsch MS; Cuzzi-Maya T; Grimaldi júnior G; Menezes JA
    Mem Inst Oswaldo Cruz; 1992; 87(4):487-92. PubMed ID: 1343662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    Motta AC; Arruda D; Souza CS; Foss NT
    Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
    Hernández DE; Oliver M; Martínez C; Planas G
    Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome.
    Nogueira-Castañon MC; Pereira CA; Furtado T
    Int J Dermatol; 1996 Apr; 35(4):295-7. PubMed ID: 8786193
    [No Abstract]   [Full Text] [Related]  

  • 5. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathology of cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis. 4. Histopathological classification].
    de Magalhães AV; Moraes MA; Raick AN; Llanos-Cuentas A; Costa JM; Cuba CC; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1986; 28(6):421-30. PubMed ID: 3602829
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
    Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
    J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected].
    Desjeux P; Mollinedo S; Le Pont F; Paredes A; Ugarte G
    Trans R Soc Trop Med Hyg; 1987; 81(5):742-6. PubMed ID: 3449990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
    Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
    Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
    Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional glucantime in Leishmania braziliensis braziliensis infections.
    Barrios LA; Costa JM; Netto EM; Vexenat CO; Cuba CC; Marsden PD
    Trans R Soc Trop Med Hyg; 1986; 80(1):173-4. PubMed ID: 3726989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
    Romero GA; Lessa HA; Macêdo VO; Carvalho EM; Barral A; Magalhães AV; Orge MG; Abreu MV; Marsden PD
    Rev Soc Bras Med Trop; 1996; 29(6):557-65. PubMed ID: 9011880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine derivatives as antileishmanial drugs.
    Vennerstrom JL; Lovelace JK; Waits VB; Hanson WL; Klayman DL
    Antimicrob Agents Chemother; 1990 May; 34(5):918-21. PubMed ID: 2360830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
    Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
    Perez-Franco JE; Cruz-Barrera ML; Robayo ML; Lopez MC; Daza CD; Bedoya A; Mariño ML; Saavedra CH; Echeverry MC
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M; Thomason TN; Franke ED
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous leishmaniasis in French Guiana: a review.
    Dedet JP
    Am J Trop Med Hyg; 1990 Jul; 43(1):25-8. PubMed ID: 2200289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
    Iguermia S; Harmouche T; Mikou O; Amarti A; Mernissi FZ
    Med Mal Infect; 2011 Jan; 41(1):47-8. PubMed ID: 20947275
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
    Goyonlo VM; Vahabi-Amlashi S; Taghavi F
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.